Back to Journals » Drug Design, Development and Therapy » Volume 11

Justification of disintegration testing beyond current FDA criteria using in vitro and in silico models

Total article views   Abstract views HTML views PDF downloads Totals
19,566 Dovepress* 9,771 3,946+ 1,320 13,717
PubMed Central* 0 5,849 430 5,849
Totals 9,771 9,795 1,750 19,566
*Since 11 April 2017
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
10 1 0 0 4 5

View citations on PubMed Central and Google Scholar